Privia Health Newsroom

Privia Health Is Maintained at Equal-Weight by Barclays

Privia Health Is Maintained at Equal-Weight by Barclays

Dow JonesMay 20 10:20 ET

Express News | Privia Health Group Inc. : Barclays Cuts Target Price to $19 From $22

ReutersMay 20 05:31 ET

Privia Health Group (PRVA) Gets a Hold From Barclays

TipRanksMay 19 21:15 ET

Privia Health Is Maintained at Buy by Truist Securities

Privia Health Is Maintained at Buy by Truist Securities

Dow JonesMay 15 10:05 ET

What 12 Analyst Ratings Have To Say About Privia Health Gr

Ratings for Privia Health Gr (NASDAQ:PRVA) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.Summarizing their recent assessments, the table b

BenzingaMay 15 10:00 ET

Express News | Privia Health Group Inc : Truist Securities Cuts Target Price to $24 From $28

ReutersMay 15 07:09 ET

Truist Securities Adjusts Price Target on Privia Health Group to $24 From $28, Keeps Buy Rating

Privia Health Group (PRVA) has an average rating of buy and price targets ranging from $21 to $31, according to analysts polled by Capital IQ.

MT NewswiresMay 15 05:14 ET

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), IN8bio (INAB) and Privia Health Group (PRVA)

TipRanksMay 14 06:01 ET

Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 13 11:54 ET

Possible Bearish Signals With Privia Health Group Insiders Disposing Stock

Privia Health Group, Inc. (NASDAQ:PRVA) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When analyzing insider transactions, it is usually mor

Simply Wall StMay 12 10:39 ET

Privia Health Is Maintained at Buy by Canaccord Genuity

Privia Health Is Maintained at Buy by Canaccord Genuity

Dow JonesMay 10 14:56 ET

Express News | Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26

BenzingaMay 10 14:46 ET

Privia Health Group Inc (PRVA) Q1 2024 Earnings: Mixed Results Amid Operational Growth

Yahoo FinanceMay 10 13:23 ET

UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating

Privia Health Group (PRVA) has an average rating of Buy and price targets ranging from $21 to $31, according to analysts polled by Capital IQ. Price: 17.85, Change: -0.18, Percent Change: -1.00

MT NewswiresMay 10 11:33 ET

Express News | Privia Health Group Inc : Evercore ISI Cuts Target Price to $23 From $25

ReutersMay 10 04:36 ET

Buy Rating Reaffirmed for Privia Health Group Amid Strong Financial Performance and Positive Growth Outlook

TipRanksMay 9 13:35 ET

Express News | Privia Health Shares Are Trading Lower After the Company Reported a Q1 Revenue Miss

BenzingaMay 9 12:30 ET

Privia Health | 10-Q: Quarterly report

Futu NewsMay 9 08:47 ET · Announcements

Express News | Privia Health Reiterates FY24 Guidance; Revenue Of $1.6B-$1.675B, Est $2.844B

BenzingaMay 9 06:30 ET

Express News | Privia Health Group Inc FY2024 Shr View $0.24, Rev View $2.84 Bln -- Lseg Ibes Data

ReutersMay 9 06:14 ET